Cargando…

Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer

Leptin, a major adipocytokine produced by adipocytes, is emerging as a key molecule linking obesity with breast cancer therefore, it is important to find effective strategies to antagonize oncogenic effects of leptin to disrupt obesity-cancer axis. Here, we examine the potential of honokiol (HNK), a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avtanski, Dimiter B., Nagalingam, Arumugam, Bonner, Michael Y., Arbiser, Jack L., Saxena, Neeraj K., Sharma, Dipali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745774/ https://www.ncbi.nlm.nih.gov/pubmed/26359358

Ejemplares similares

Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
por: Avtanski, Dimiter B., et al.
Publicado: (2015)

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
por: Nagalingam, Arumugam, et al.
Publicado: (2012)

Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis
por: Nagalingam, Arumugam, et al.
Publicado: (2017)

Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment
por: Muniraj, Nethaji, et al.
Publicado: (2020)

Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB
por: Nagalingam, Arumugam, et al.
Publicado: (2021)

Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes
por: Xie, Bei, et al.
Publicado: (2017)

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016)

Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3
por: Pillai, Vinodkumar B., et al.
Publicado: (2015)

Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma
por: Siddharth, Sumit, et al.
Publicado: (2022)

Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice
por: Kuppusamy, Panjamurthy, et al.
Publicado: (2017)

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies
por: Mędra, Aleksandra, et al.
Publicado: (2016)

Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018)

PMON211 Energy metabolism hormones irisin and leptin affect steroidogenesis in human granulosa cells: in vitro studies
por: Avtanski, Dimiter, et al.
Publicado: (2022)

In vitro treatment of human granulosa cells with irisin and leptin: Quantitative RT-PCR array data (female infertility panel)
por: Stojchevski, Radoslav, et al.
Publicado: (2022)

The Effects of Leptin and Irisin on Steroidogenic Enzyme Gene Expression in Human Ovarian Granulosa Cells - Initial Studies
por: Avtanski, Dimiter Bogdanov, et al.
Publicado: (2021)

The effects of irisin and leptin on steroidogenic enzyme gene expression in human granulosa cells: In vitro studies
por: Poretsky, Leonid, et al.
Publicado: (2023)

Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
por: Okuda, Keiichiro, et al.
Publicado: (2021)

Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis
por: Wang, Xu, et al.
Publicado: (2014)

Targeting the Vulnerabilities of Oncogene Activation
por: Huang, Christina, et al.
Publicado: (2023)

RhoBTB Proteins Regulate the Hippo Pathway by Antagonizing Ubiquitination of LKB1
por: Nguyen, Thanh Hung, et al.
Publicado: (2020)

Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
por: Zang, Hongjing, et al.
Publicado: (2020)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2023)

LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022)

Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
por: Pillai, Vinodkumar B., et al.
Publicado: (2017)

Honokiol antagonizes doxorubicin-induced cardiomyocyte senescence by inhibiting TXNIP-mediated NLRP3 inflammasome activation
por: Huang, Pian-Pian, et al.
Publicado: (2020)

Phyto-polyphenols as potential inhibitors of breast cancer metastasis
por: Avtanski, Dimiter, et al.
Publicado: (2018)

Exploring Leptin Antagonism in Ophthalmic Cell Models
por: Scolaro, Laura, et al.
Publicado: (2013)

Establishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells
por: da Costa, Adilson, et al.
Publicado: (2020)

SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
por: Zubiete-Franco, Imanol, et al.
Publicado: (2018)

Resistin and adenylyl cyclase-associated protein 1 (CAP1) regulate the expression of genes related to insulin resistance in BNL CL.2 mouse liver cells
por: Avtanski, Dimiter, et al.
Publicado: (2019)

Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain
por: Lin, Yi-Ruu, et al.
Publicado: (2009)

Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis
por: Subramaniam, Dharmalingam, et al.
Publicado: (2021)

LKB1 pro‐oncogenic activity triggers cell survival in circulating tumor cells
por: Trapp, Elisabeth Katharina, et al.
Publicado: (2017)

The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo
por: Rackley, Briana, et al.
Publicado: (2021)

Honokiol Antagonizes Cadmium-Induced Nephrotoxicity in Quail by Alleviating Autophagy Dysfunction, Apoptosis and Mitochondrial UPR Inhibition with Its Antioxidant Properties
por: Zhang, Kanglei, et al.
Publicado: (2022)

Antineoplastic Effects of Honokiol on Melanoma
por: Guillermo-Lagae, Ruth, et al.
Publicado: (2017)

The application prospects of honokiol in dermatology
por: Li, Yao, et al.
Publicado: (2022)

Correction: da Costa et al. Establishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells. Cancers 2020, 12, 395
por: da Costa, Adilson, et al.
Publicado: (2021)

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
por: Kataoka, Seita, et al.
Publicado: (2021)

Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis
por: Zhang, Qing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iepl3duehjgrvtvff721dqp0sd